Loading company details...
Beta
Latest Form 4 (May 23, 2024): Timothy M. Mayleben (Director): Disposition to Issuer of 1,800 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 23, 2024 | Timothy M. Mayleben | Disposition to Issuer | 1,800 | n/a |
| May 23, 2024 | Tiago Girao | Disposition to Issuer | 1,800 | n/a |
| May 23, 2024 | Fred Callori | Disposition to Issuer | 1,800 | n/a |
| May 23, 2024 | Alka Batycky | Disposition to Issuer | 3,600 | n/a |
| May 23, 2024 | Roger Adsett | Disposition to Issuer | 1,800 | n/a |
| May 23, 2024 | Christopher Nishan Garabedian | Disposition to Issuer | 1,800 | n/a |
| May 23, 2024 | Fabio Cataldi, Chief Medical Officer | Disposition to Issuer | 48,813 | n/a |
| May 23, 2024 | Gregory Oakes, Chief Executive Officer | Disposition to Issuer | 54,454 | n/a |
| Mar 4, 2024 | Fabio Cataldi, Chief Medical Officer | Grant/Award | 21,138 | n/a |
| Mar 4, 2024 | Gregory Oakes, Chief Executive Officer | Grant/Award | 54,454 | n/a |